NNVC
Price
$1.52
Change
-$0.02 (-1.30%)
Updated
Jun 9, 02:49 PM (EDT)
Capitalization
24.75M
86 days until earnings call
VERV
Price
$6.00
Change
-$0.21 (-3.39%)
Updated
Jun 9, 03:17 PM (EDT)
Capitalization
552.24M
59 days until earnings call
Interact to see
Advertisement

NNVC vs VERV

Header iconNNVC vs VERV Comparison
Open Charts NNVC vs VERVBanner chart's image
NanoViricides
Price$1.52
Change-$0.02 (-1.30%)
Volume$100
Capitalization24.75M
Verve Therapeutics
Price$6.00
Change-$0.21 (-3.39%)
Volume$2.73K
Capitalization552.24M
NNVC vs VERV Comparison Chart
Loading...
NNVC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VERV
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
NNVC vs. VERV commentary
Jun 09, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is NNVC is a Hold and VERV is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 09, 2025
Stock price -- (NNVC: $1.66 vs. VERV: $4.24)
Brand notoriety: NNVC and VERV are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: NNVC: 206% vs. VERV: 74%
Market capitalization -- NNVC: $24.75M vs. VERV: $552.24M
NNVC [@Biotechnology] is valued at $24.75M. VERV’s [@Biotechnology] market capitalization is $552.24M. The market cap for tickers in the [@Biotechnology] industry ranges from $334.5B to $0. The average market capitalization across the [@Biotechnology] industry is $2.25B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

NNVC’s FA Score shows that 0 FA rating(s) are green whileVERV’s FA Score has 1 green FA rating(s).

  • NNVC’s FA Score: 0 green, 5 red.
  • VERV’s FA Score: 1 green, 4 red.
According to our system of comparison, NNVC is a better buy in the long-term than VERV.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

NNVC’s TA Score shows that 6 TA indicator(s) are bullish while VERV’s TA Score has 3 bullish TA indicator(s).

  • NNVC’s TA Score: 6 bullish, 4 bearish.
  • VERV’s TA Score: 3 bullish, 5 bearish.
According to our system of comparison, NNVC is a better buy in the short-term than VERV.

Price Growth

NNVC (@Biotechnology) experienced а +13.70% price change this week, while VERV (@Biotechnology) price change was +0.24% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +10.68%. For the same industry, the average monthly price growth was +19.57%, and the average quarterly price growth was +6.76%.

Reported Earning Dates

NNVC is expected to report earnings on Sep 03, 2025.

VERV is expected to report earnings on Aug 07, 2025.

Industries' Descriptions

@Biotechnology (+10.68% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
VERV($552M) has a higher market cap than NNVC($24.8M). NNVC YTD gains are higher at: 16.084 vs. VERV (-24.823). NNVC has higher annual earnings (EBITDA): -8.59M vs. VERV (-221.91M). VERV has more cash in the bank: 524M vs. NNVC (3.96M). NNVC has less debt than VERV: NNVC (1.5M) vs VERV (70M). VERV has higher revenues than NNVC: VERV (32.3M) vs NNVC (0).
NNVCVERVNNVC / VERV
Capitalization24.8M552M4%
EBITDA-8.59M-221.91M4%
Gain YTD16.084-24.823-65%
P/E RatioN/AN/A-
Revenue032.3M-
Total Cash3.96M524M1%
Total Debt1.5M70M2%
FUNDAMENTALS RATINGS
NNVC: Fundamental Ratings
NNVC
OUTLOOK RATING
1..100
14
VALUATION
overvalued / fair valued / undervalued
1..100
40
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
98
PRICE GROWTH RATING
1..100
41
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
85

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
NNVCVERV
RSI
ODDS (%)
Bearish Trend 13 days ago
90%
N/A
Stochastic
ODDS (%)
Bearish Trend 13 days ago
88%
Bullish Trend 13 days ago
71%
Momentum
ODDS (%)
Bullish Trend 13 days ago
85%
Bullish Trend 13 days ago
79%
MACD
ODDS (%)
Bullish Trend 13 days ago
83%
Bearish Trend 13 days ago
90%
TrendWeek
ODDS (%)
Bullish Trend 13 days ago
80%
Bearish Trend 13 days ago
88%
TrendMonth
ODDS (%)
Bullish Trend 13 days ago
79%
Bearish Trend 13 days ago
88%
Advances
ODDS (%)
Bullish Trend 21 days ago
78%
Bullish Trend 25 days ago
85%
Declines
ODDS (%)
Bearish Trend 13 days ago
86%
Bearish Trend 13 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 13 days ago
90%
N/A
Aroon
ODDS (%)
Bullish Trend 13 days ago
83%
Bearish Trend 13 days ago
88%
View a ticker or compare two or three
Interact to see
Advertisement
NNVC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VERV
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
AAPL200.420.21
+0.10%
Apple
SPY587.73-3.42
-0.58%
SPDR® S&P 500® ETF
BTC.X107802.330000-1192.312500
-1.09%
Bitcoin cryptocurrency
TSLA356.90-5.99
-1.65%
Tesla
GME31.21-3.80
-10.85%
GameStop Corp

NNVC and

Correlation & Price change

A.I.dvisor indicates that over the last year, NNVC has been loosely correlated with ZNTL. These tickers have moved in lockstep 34% of the time. This A.I.-generated data suggests there is some statistical probability that if NNVC jumps, then ZNTL could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NNVC
1D Price
Change %
NNVC100%
-2.92%
ZNTL - NNVC
34%
Loosely correlated
+4.17%
CGEM - NNVC
33%
Poorly correlated
+0.26%
CVAC - NNVC
32%
Poorly correlated
+2.07%
VERV - NNVC
30%
Poorly correlated
-1.17%
VXRT - NNVC
30%
Poorly correlated
-2.36%
More

VERV and

Correlation & Price change

A.I.dvisor indicates that over the last year, VERV has been loosely correlated with BEAM. These tickers have moved in lockstep 59% of the time. This A.I.-generated data suggests there is some statistical probability that if VERV jumps, then BEAM could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To VERV
1D Price
Change %
VERV100%
-1.17%
BEAM - VERV
59%
Loosely correlated
-0.88%
CRSP - VERV
55%
Loosely correlated
-0.92%
RXRX - VERV
51%
Loosely correlated
+0.11%
XNCR - VERV
50%
Loosely correlated
-2.58%
ARWR - VERV
50%
Loosely correlated
+1.24%
More